Whitehawk Therapeutics (WHWK) Leases (2019 - 2024)
Whitehawk Therapeutics (WHWK) has disclosed Leases for 6 consecutive years, with $787000.0 as the latest value for Q4 2024.
- Quarterly Leases fell 32.68% to $787000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $787000.0 through Dec 2024, down 32.68% year-over-year, with the annual reading at $787000.0 for FY2024, 32.68% down from the prior year.
- Leases for Q4 2024 was $787000.0 at Whitehawk Therapeutics, down from $886000.0 in the prior quarter.
- The five-year high for Leases was $1.7 million in Q2 2022, with the low at $9452.0 in Q2 2021.
- Average Leases over 5 years is $829310.9, with a median of $886000.0 recorded in 2024.
- The sharpest move saw Leases plummeted 91.76% in 2021, then soared 17388.36% in 2022.
- Over 5 years, Leases stood at $89761.0 in 2020, then skyrocketed by 520.54% to $557000.0 in 2021, then surged by 173.25% to $1.5 million in 2022, then decreased by 23.19% to $1.2 million in 2023, then plummeted by 32.68% to $787000.0 in 2024.
- According to Business Quant data, Leases over the past three periods came in at $787000.0, $886000.0, and $982000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.